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outward deviation of the right eye for 20 years showed
normal visual acuities and ocular findings in the ophthal-
mology examination. She had limitations in multiple di-
rections of gaze, but no ptosis (Figure 1A). Krimsky I test
showed exotropia of > 50D and right hypertropia of 45D.
Laboratory findings were negative for antiacetylcholine-
receptor, antinuclear, antimitochondrial, and antithyr-
oglobulin antibodies. The comprehensive metabolic panel
was within normal limits. Imaging study only showed atro-
phy of the extraocular muscles (EOMs). Chronic progressive
external ophthalmoplegia (CPEO) was suspected; however,
genetic testing using polymerase chain reaction (PCR) and
restriction fragment length polymorphism showed no
A8344G or A3243G gene mutations in the blood.Conflicts of interest: The authors have no conflicts of interest
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recession of the right lateral rectus muscle by 9.5 mm and
resections of the right medial and right inferior rectus
muscles of 8.5 mm and 7.5 mm, respectively. Eye position
measurement revealed right hypertropia of 12D post-
operatively, with improved range of binocular single vision
and appearance (Figure 1B).
Histopathological examination of the EOM specimens
showed generalized atrophic myocytes, increased central
nucleation, and extensive endomysial fibrosis with hema-
toxylin and eosin staining (Figure 1C). Gomori trichrome
staining revealed the presence of typical ragged-red fibers
with sub-sarcolemmal accumulation (Figure 1D). Trans-
mission electron microscopy showed abnormal mitochon-
dria with aberrant fingerprint-like morphology and widened
cristae with electron-dense accumulation (Figure 1E).
Further genetic testing revealed a large 4977-bp deletion in
the mitochondrial DNA (mtDNA) of the EOM tissue but not in
the blood, compatible with the diagnosis of CPEO
(Figure 1F).
CPEO, a mitochondrial disease characterized by bilateral
ptosis and progressive extraocular muscle limitation in
multiple directions of gaze, was first described in 1868 byd by Elsevier Taiwan LLC. This is an open access article under the
/4.0/).
Figure 1 (A) Clinical photographs of the patient show gaze paresis in multiple directions in the right eye; (B) improved range of
motion in the right eye after two-step strabismus surgery; (CeE) histopathological examination of the extra-ocular muscle (EOM)
biopsy; (C) microscopically, hematoxylin and eosin (H&E) staining shows marked variation in fiber size with generalized atrophic
myocytes (arrow), increased central nucleation, discernible regenerative myocytes, and extensive endomysial fibrosis. No in-
flammatory cell infiltrate is seen; (D) gomori-trichrome stain shows the presence of ragged-red fibers with sub-sarcolemmal
accumulation (arrow), seen as hematoxylin aggregates in H&E staining, suggesting mitochondrial myopathy; (E) transmission
electron microscopy was performed on the EM-processed tissue showing characteristic myofibrils of the skeletal muscle. Abnormal
mitochondria, including aberrant fingerprint-like morphology and widened cristae with electron-dense accumulation (arrow) is
frequently observed; (F) polymerase chain reaction (PCR) analysis of samples from the EOM demonstrated a large 4977-bp deletion
in the mitochondrial DNA, but not in the blood of the patient. Lane 1Z blood sample from a healthy individual; Lane 2Z blood
sample from the patient; Lane 3Z EOM DNA from the patient. EOMZ extra-ocular muscle; MZmaker; NCZ negative control;
PCZ positive control.
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mtDNA or associated nuclear DNA mutations are associated
with a wild range of multi-systemic disease. Multiple in-
dependent factors influence the clinical expression of a
mutation, including tissue distribution, heteroplasmy level,
and the organ’s dependence on oxidative metabolism. The
most common mtDNA mutation is a single, large-scale
deletion w 2e10 kb long; the deletion breakpoints are
often flanked by short direct repeats.2 This mutation type is
associated with particular phenotypes, including CPEO,
Kearns-Sayre syndrome (KSS), and Pearson’s marrow-
pancreases syndrome. Unlike KSS, in which partially
deleted mtDNAs are present in all examined tissues and
mother-to-offspring transmission of rearranged mtDNA
species might occur,3 deletion of mtDNA is found only in
EOM in CPEO patients, implying that the mutation occurs
after fertilization in the muscle lineage of the mesoderm.4
Therefore, chances of mother to offspring transmission are
lower. Fresnel prisms, eyelid crutches, and surgery are
modalities to improve double vision and lid droop in pa-
tients with CPEO. Modified surgical dosage of the EOM by
exceeding the corrections suggested by standard strabismus
tables were recommended to prevent recurrence.5In conclusion, our case demonstrates that patients with
CPEO may benefit from strabismus surgery both function-
ally and cosmetically, and that histopathological and ge-
netic testing of EOM specimen is essential for confirming
the diagnosis in patients with ophthalmoplegia.References
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